Open Access

Use of histone deacetylase inhibitors (HDACis) in pancreatic ductal adenocarcinoma (PDAC): A narrative review

Vassiliki Tarara

Vassiliki Tarara

Laboratory of Histology and Embryology, Aristotle University of Thessaloniki, School of MedicineThessaloniki, Greece
Search for this author on
Sciendo|Google Scholar
Tarara, Vassiliki
 and 
Evangelos Karamitrousis

Evangelos Karamitrousis

Medical Oncology Department, School of Medicine, Aristotle University of Thessaloniki, Papageorgiou General HospitalThessaloniki, Greece
Search for this author on
Sciendo|Google Scholar
Karamitrousis, Evangelos
  
Jul 12, 2025
Use of histone deacetylase inhibitors (HDACis) in pancreatic ductal adenocarcinoma (PDAC): A narrative review's Cover Image
About this article
Previous Article
Next Article
Cite
Download Cover
Article Category: Research Article
Published Online: Jul 12, 2025
Received: Oct 06, 2024
Accepted: Dec 23, 2024
DOI: https://doi.org/10.2478/fco-2024-0007
Keywords
© 2025 Vassiliki Tarara et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Language:
English
Publication timeframe:
2 times per year
Journal Subjects:
Medicine, Clinical Medicine, Internal Medicine, Haematology, Oncology
Journal RSS Feed